Skip to main content

Advertisement

SpringerLink
Log in

Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

We report the long-term follow-up in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy (NACT) + radical surgery (RS) + adjuvant chemotherapy (ACT) analyzing prognostic factors which may more influence, in a long time, the survival outcome using univariate and multivariate analysis. In this study, we included all patients with diagnosis of locally advanced cervical cancer (IB2-IIB) treated with NACT + RS + ACT from June 2000 and February 2007 as previously described by Angioli et al. (Gynecol Oncol 127(2):290–6, 2012). The primary end-point of the study was overall survival (OS) in patients with node metastases and in those without positive lymph nodes at the end of 10-year follow-up in order to confirm the prognostic role of nodes involvement for a long period. Moreover, we analyzed the impact of other prognostic factors, such as histotype, tumor size, grading and parametrial invasion. Secondary end-point was evaluated in the subgroup of patients with positive nodes the following prognostic factors: number of positive lymph nodes and site of positive lymph nodes. In the subgroup of patients with positive nodes, the OS was 63 %, and in that with negative nodes, the OS was 75 %. On multivariate analysis, the number of nodal metastases, parametrial involvement, grading and the lesion diameter were noted to be significant factors in determining OS. Neither the histotype nor the lymph nodal site is related to survival. Results suggest that CT alone may be an alternative postoperative therapy for patients with cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. (2012) GLOBOCAN 2012 v1. 0, Cancer incidence and mortality worldwide: IARC cancer Base No. 11. Lyon, France: International Agency for Research [on-line]. http://globocan.iarc.fr.

  2. Peters WA III, Liu PY, Barrett R, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–13.

    CAS  PubMed  Google Scholar 

  3. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–43.

    Article  CAS  PubMed  Google Scholar 

  4. Keys HM, Bundy BN, Stehman FB, et al. A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: a randomized trial of the Gynecology Oncology Group. N Engl J Med. 1999;340:1154–61.

    Article  CAS  PubMed  Google Scholar 

  5. Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F, Zola P, Mangioni C, Landoni F. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20(1):179–88.

    Article  CAS  PubMed  Google Scholar 

  6. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based chemoradiation improves progression-free survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group study. N Engl J Med. 1999;340:1144–53.

    Article  CAS  PubMed  Google Scholar 

  7. Wong LC, Ngan HYS, Cheung ANY, et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol. 1999;17:2055–60.

    CAS  PubMed  Google Scholar 

  8. Roberts KB, Urdaneta N, Vera R, et al. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. Int J Cancer. 2000;90:206–23.

    Article  CAS  PubMed  Google Scholar 

  9. Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002;20:966–72.

    Article  CAS  PubMed  Google Scholar 

  10. Rydzewska L, Tierney J, Vale CL, Symonds PR. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev. 2010;(1):CD007406.

  11. Sardi J, Sananes C, Giaroli A, et al. Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomized controlled trial. Int J Gynecol Cancer. 1998;8:441–50.

    Article  Google Scholar 

  12. Chen H, Liang C, Zhang L, Huang S, Wu X. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study. Gynecol Oncol. 2008;110(3):308–15.

    Article  CAS  PubMed  Google Scholar 

  13. Cho YH, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer. J Gynecol Oncol. 2009;20(1):22–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Eddy GL, Bundy BN, Creasman WT, Spirtos NM, Mannel RS, Hannigan E. O’Connor D Treatment of (“bulky”) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol. 2007;106(2):362–9 Epub 2007 May 9.

    Article  CAS  PubMed  Google Scholar 

  15. Lissoni AA, Colombo N, Pellegrino A, Parma G, Zola P, Katsaros D, Chiari S, Buda A, Landoni F, Peiretti M, Dell’anna T, Fruscio R, Signorelli M, Grassi R, Floriani I, Fossati R, Torri V, Rulli E. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009;20(4):660–5.

    Article  CAS  PubMed  Google Scholar 

  16. Sardi J, Sananes C, Giaroli A, Maya G, di Paola G. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol. 1990;38(3):486–93.

    Article  CAS  PubMed  Google Scholar 

  17. Tattersall MHN, Amirez C, Oppleson M. A Randomized trial of adjuvant chemotherapy after radical hysterectomy in stage lb-lla cervical cancer patients with pelvic lymph node metastases. Gynaec Oncol. 1992;46:176–81.

    Article  CAS  Google Scholar 

  18. Mossa B, Mossa S, Marziani R. Adjuvant chemotherapy versus radiation therapy after radical surgery in high-risk positive node Stage IB/IIA cervical cancer. Eur J Gynaec Oncol. 2010;31(5):545–50.

    CAS  Google Scholar 

  19. Takeshima Nobuhiro, Umayahara Kenji, Fujiwara Kiyoshi, Hirai Yasuo, Takizawa Ken. Katsuhiko Hasumi treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB–IIA cervical cancer. Gynecol Oncol. 2006;103(2):618–22 Epub 2006 Jun 14.

    Article  CAS  PubMed  Google Scholar 

  20. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol. 1999;73(2):177–83.

    Article  CAS  PubMed  Google Scholar 

  21. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol. 1975;46:507–10.

    CAS  PubMed  Google Scholar 

  22. Fuller AF, Elliott N, Kosloff C, Lewis JL. Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment. Gynecol Oncol. 1982;13:165–74.

    Article  PubMed  Google Scholar 

  23. Mohar A, Frias-Mendivil M. Epidemiology of cervical cancer. Cancer Invest. 2000;18:584–90.

    Article  CAS  PubMed  Google Scholar 

  24. Mendenhall WM, Thar TL, Bova FJ, Marsuc RB, Morgan LS, Million RR. Prognostic and treatment factors affecting pelvic control of Stage Ib-IIa-b carcinoma of the intact uterine cervix treated with radiation alone. Cancer. 1984;53:2649–54.

    Article  CAS  PubMed  Google Scholar 

  25. Thar TL, Million RR, Daly JW. Radiation treatment of carcinoma of the cervix. Semin Oncol. 1982;9:299–311.

    CAS  PubMed  Google Scholar 

  26. Van Nagell JR, Rayburn W, Donaldson ES. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer. 1979;44:2354–61.

    Article  PubMed  Google Scholar 

  27. Boyce J, Fruchter RO, Nicasti AD, Amliavegar PC, Reinis MS, Nelson JH. Prognostic factors in Stage I carcinoma of the cervix. Gynecol Oncol. 1981;12:154–65.

    Article  CAS  PubMed  Google Scholar 

  28. Chung CK, Nahhas WS, Stryker JA, Curry SL, Abt AB, Mortel R. Analysis of factors contributing to treatment failures in Stages Ib and IIa carcinoma of the cervix. Am J Obstet Gynecol. 1980;l38:550–6.

    Article  Google Scholar 

  29. Chung CK, Stryker JA, Ward SP, Nahhas WA, Mortel R. Histologic grade and prognosis of carcinoma of the cervix. Obstet Gynecol. 1981;57:636–42.

    CAS  PubMed  Google Scholar 

  30. Perez CA, Breaux S, Madoc-Jones H, Bedeomek TM, Camel HM, Purdy JA, Walz BJ. Radiation therapy alone in the treatment of carcinoma of uterine cervix. 1. Analysis of tumour recurrence. Cancer. 1983;51:1393–402.

    Article  CAS  PubMed  Google Scholar 

  31. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. JCO. 2008;26:5802–12.

    Article  Google Scholar 

  32. Angioli R, Plotti F, Montera R, Aloisi A, Luvero D, Capriglione S, Terranova C, De Cicco Nardone C, Muzii L, Benedetti-Panici P. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer. Gynecol Oncol. 2012;127(2):290–6.

    Article  CAS  PubMed  Google Scholar 

  33. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–6.

    Article  CAS  PubMed  Google Scholar 

  34. Hosaka Masayoshi, Watari Hidemichi, Takeda Mahito, Moriwaki Masashi, Hara Yoko, Todo Yukiharu, Ebina Yasuhiko, Sakuragi Noriaki. Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy. J. Obstet. Gynaecol. Res. 2008;34(4):552–6.

    Article  PubMed  Google Scholar 

  35. Angioli R, Luvero D, Aloisi A, Capriglione S, Gennari P, Linciano F, Li Destri M, Scaletta G, Montera R, Plotti F. Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature. Expert Rev Anticancer Ther. 2014;14(4):431–9.

    Article  CAS  PubMed  Google Scholar 

  36. Sardi J, Giaroli A, Sananes C, et al. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma of the cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer. 1996;6:85–93.

    Article  Google Scholar 

  37. Dische S. Radiotherapy of cervical cancer. Clin Obstet Gynaecol. 1985;12:203–27.

    CAS  PubMed  Google Scholar 

  38. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW Jr. Complications of combined radical hysterectomy—postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol. 1989;32:292–6.

    Article  CAS  PubMed  Google Scholar 

  39. Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol Oncol. 1994;54:4–9.

    Article  CAS  PubMed  Google Scholar 

  40. Morrow PC. Panel report. Is pelvic radiation beneficial in the postoperative management of Stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol. 1980;10:105.

    Article  Google Scholar 

  41. Angioli R, Plotti F, Aloisi A, Scaletta G, Capriglione S, Luvero D, Fiore L, Terranova C, Montera R, Panici PB. A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery. Gynecol Oncol. 2015;139(3):433–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, Campus Bio Medico University of Rome, Via Alvaro del Portillo, 200-00128, Rome, Italy

    Daniela Luvero, Francesco Plotti, Alessia Aloisi, Stella Capriglione, Roberto Ricciardi, Andrea Miranda, Salvatore Lopez, Giuseppe Scaletta, Giovanna De Luca & Roberto Angioli

  2. Department of Obstetrics and Gynaecology, “Sapienza” University of Rome, Rome, Italy

    Pierluigi Benedetti-Panici

Authors
  1. Daniela Luvero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Plotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessia Aloisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stella Capriglione
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roberto Ricciardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrea Miranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Salvatore Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giuseppe Scaletta
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Giovanna De Luca
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Pierluigi Benedetti-Panici
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Roberto Angioli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stella Capriglione.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luvero, D., Plotti, F., Aloisi, A. et al. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up. Med Oncol 33, 110 (2016). https://doi.org/10.1007/s12032-016-0830-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-016-0830-0

Keywords

Search

Navigation